676 filings
Page 5 of 34
S-8
5yedc5bj
6 Aug 20
Registration of securities for employees
4:41pm
8-K
my21w ck8k1utga6h
6 Aug 20
Dynavax Announces Second Quarter 2020 Financial Results
4:06pm
8-K
ebx82p6 qgbk6c9ujbu9
21 Jul 20
Departure of Directors or Certain Officers
4:43pm
S-3ASR
v1jn5i
2 Jul 20
Automatic shelf registration
4:37pm
8-K
ivqj14 n0jsam9
19 Jun 20
Preclinical results demonstrated the ability of CpG 1018-adjuvanted SCB-2019 to elicit neutralizing antibodies in multiple animal species
4:05pm
8-K
si74 1qfg9f2a925ik1
29 May 20
Departure of Directors or Certain Officers
4:10pm
DEFA14A
ggs08
22 May 20
Additional proxy soliciting materials
4:54pm
8-K
bw6p7 w37cdlkrcv
22 May 20
Other Events
4:52pm
424B5
wvbivx
22 May 20
Prospectus supplement for primary offering
4:50pm
8-K
ogfmwyu 6cfo06
21 May 20
Other Events
4:07pm
424B5
vsrbv8b
21 May 20
Prospectus supplement for primary offering
4:06pm
8-K
m0rr54 virreatxzgl9c
18 May 20
Other Events
5:02pm
8-K
sme1blp7zt8 7wmow
11 May 20
Departure of Directors or Certain Officers
4:10pm
8-K
9u0w1ju4unxdj1a2dr
7 May 20
Dynavax Announces First Quarter 2020 Financial Results
4:17pm
EFFECT
z0ddy89t22tnio
1 May 20
Notice of effectiveness
12:15am
DEFA14A
9yndiws3jm
17 Apr 20
Additional proxy soliciting materials
5:02pm